Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

11.99

-0.38 (-3.07%)

Oct 8, 2026, 11:44 AM EDT - Market open

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	349	256	220	235	1,075	1,148
Market Cap Growth	58.16%	16.57%	-6.67%	-78.12%	-6.39%	24.98%
Enterprise Value	320	259	173	73	809	784
Last Close Price	12.37	11.97	10.36	11.17	51.87	56.81

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Forward PE	-	6.26	6.26	6.26	6.26	105.09
PS Ratio	5.36	3.92	3.25	2.97	12.48	11.83
PB Ratio	3.56	3.95	1.70	1.09	3.35	2.88
P/TBV Ratio	3.46	3.95	1.70	1.09	3.35	2.88
PEG Ratio	-	1.82	1.82	1.82	1.82	1.82

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
EV/Sales Ratio	4.91	3.96	2.56	0.93	9.39	8.08

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Debt / Equity Ratio	1.80	3.11	1.76	1.03	0.08	0.02
Net Debt / Equity Ratio	-0.29	0.19	-0.17	-0.68	-0.78	-0.86
Net Debt / EBITDA Ratio	0.55	-0.15	0.19	1.09	2.08	3.25
Net Debt / FCF Ratio	0.80	-0.38	0.23	1.31	2.90	4.89
Asset Turnover	0.22	0.20	0.16	0.19	0.21	0.21
Quick Ratio	3.62	4.03	4.99	6.52	10.00	8.43
Current Ratio	3.76	4.21	5.21	6.73	10.45	8.82
Return on Equity (ROE)	-70.12%	-84.63%	-67.16%	-49.74%	-33.78%	-18.48%
Return on Assets (ROA)	-12.28%	-16.23%	-18.13%	-20.47%	-19.01%	-14.81%
Return on Invested Capital (ROIC)	-50.40%	-92.97%	-138.32%	-163.29%	-94.88%	-91.02%
Return on Capital Employed (ROCE)	-24.20%	-36.80%	-38.10%	-34.30%	-35.80%	-27.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-18.08%	-32.00%	-52.86%	-56.90%	-11.33%	-6.88%
FCF Yield	-10.56%	-12.57%	-44.06%	-47.71%	-8.08%	-6.16%
Buyback Yield / Dilution	-27.12%	-0.85%	-0.90%	-1.78%	-2.14%	-1.16%

SEC Filings: 10-K · 10-Q